This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARNA at https://www.zacks.com/ap/ARNA
1. Arrowhead Pharmaceuticals Inc. (ARWR) Gained 24.73% to close Wednesday's (Jan.3) trading at $4.64. The stock hit a new intraday high of $4.88. News: No news Pipeline: In 2016, Arrowhead had to discontinue development of prior …
Shares of Arena Pharmaceuticals (NASDAQ: ARNA), a small cap biotech ... the underwriters a 30‑day option to purchase another 9 million shares of common stock. While it's never a great idea to tap the public markets for funds when your …
On the smaller side Arena Pharmaceuticals (NASDAQ:ARNA) may want to gatecrash the party. The fundamental buy argument here which the potential bidders are backing is the way that Vectura is cash rich, debt free, and with potential …
The project would be undertaken in collaboration with Israel-based farming solutions provider ARNA. Punjab Chief Minster Amarinder Singh today gave in- principle approval for the pilot project to provide affordable technical knowhow to the …
Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod …
The historical 35-40% of the time we have underperformed usually came in a stock market environment where a narrow group of stocks were very popular and appeared to be the “only game in town.” We have been in one of these for a …